• Mashup Score: 1
    Hans-Peter Kiem, M.D., Ph.D. - 2 year(s) ago

    Dr. Kiem is a physician-scientist studying hematopoietic stem cell (HSC) biology, transplantation,…

    Source: asgct.org
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of fredhutch
      fredhutch

      Closing out #ASGCT22 with a warm congratulations to Dr. Hans-Peter Kiem @HPKiem of Fred Hutch as he steps into his role as president of @ASGCTherapy. https://t.co/hJkaayeIyK https://t.co/u879oUscU5

  • Mashup Score: 3
    Introducing Our 2022 Annual Meeting Award Winners - 2 year(s) ago

    The American Society of Gene @ Cell Therapy is proud to announce the winners of the Outstanding Achievement Award, the Outstanding New Investigator Award, the Sonia Skarlatos Public Service Award, and the Jerry Mendell Award for Translational Science.

    Source: asgct.org
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of fredhutch
      fredhutch

      Congrats to Dr. Christopher Peterson of Fred Hutch on receiving the Outstanding New Investigator Award at #ASGCT22! Peterson is recognized for his work in the lab of @HPKiem, which he joined with the specific interest to pursue research in #HIV. https://t.co/rCH3rIVthR https://t.co/B9AmKGuhqV

  • Mashup Score: 1
    Cell Press: Molecular Therapy - 2 year(s) ago

    Suppression of RNA editing by miR-17 inhibits the stemness of melanoma stem cellsMiR-17 inhibits RNA editing to achieve post-transcriptional regulation of DOCK2, leading to the suppression of the stemness of melanoma stem cells. Our findings indicate that miRNA-regulated RNA editing plays important roles in tumor progression and that miR-17, a tumor suppressor, may be a potential therapeutic…

    Source: www.cell.com
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CellPressNews
      CellPressNews

      The response to the “call for papers” for the @MolTherapy special issue on expanding the scope and scale of gene editing was so great that we now bring you a virtual special issue on gene editing from across the family of journals. #ASGCT22 https://t.co/bfLvwVOcTt https://t.co/rbGnwqJ1kt

  • Mashup Score: 0
    Agenda Details | ASGCT 25th Annual Meeting - 2 year(s) ago

    Wednesday, May 18 2022 08:50 AM – 09:15 AM ET. Breaking Down Gene Therapy and CRISPR Topics for Non-scientific Audiences Jennifer E. Adair, PhD. Fred Hutch, Seattle, WA …

    Source: annualmeeting.asgct.org
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of fredhutch
      fredhutch

      Fred Hutch at #ASGCT22 | Dr. Jennifer Adair presents "Breaking Down Gene Therapy and CRISPR Topics for Non-scientific Audiences" 🗓️ Wednesday, May 18, 8:50 a.m. ET | Room 206 https://t.co/D6m4tL5vJJ https://t.co/ckAoYeR8ZT

  • Mashup Score: 0
    Agenda Details | ASGCT 25th Annual Meeting - 2 year(s) ago

    Wednesday, May 18 2022 08:00 AM – 09:45 AM ET. Challenges and Status in Development of Gene Therapies in LMICs (Organized by the Global Outreach Committee) This symposium will highlight the barriers to the development of gene therapies in…

    Source: annualmeeting.asgct.org
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of fredhutch
      fredhutch

      Fred Hutch at #ASGCT22 | Dr. Jennifer Adair: Investigator Perspective on Improving Transportability of Gene Therapies in Low- and Middle-income Countries (LMICs). 🗓️ Wednesday, May 18, 8 a.m. ET | Room 102 https://t.co/Vpylo7RFyp https://t.co/uBbG7Udw3E

Load More